Forton Pharmaceuticals Private Limited
About Forton Pharmaceuticals Private Limited
Data last updated:
Forton Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 26 November 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U93000PN2012PTC145510. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vinod Jijeba Gote and Shital Lalitkumar Kabra.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2019, the company reported a revenue of ₹32.12 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹1.55 Lakh (net margin 4.8%) and EBITDA of ₹1.66 Lakh (EBITDA margin 5.2%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Forton Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 4 Amey Co – Operative Housing Society V – 10 Indira Shankar Nagri Paud Road K, Othrud, Pune, Maharashtra, India – 411038
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Forton Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Forton Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Forton Pharmaceuticals Private Limited, buy the company report.
Financials of Forton Pharmaceuticals Private Limited
FY 2019 filings availableForton Pharmaceuticals Private Limited reported revenue of ₹32.12 Lakh (up 4% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 10%. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹32.12 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 4.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Forton Pharmaceuticals Private Limited, buy the company report.
Board of directors of Forton Pharmaceuticals Private Limited
Forton Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Jijeba Gote | Director | 26 Nov 2012 | 13 Years 11 Months | Current |
| Shital Lalitkumar Kabra | Director | 26 Nov 2012 | 13 Years 11 Months | Current |
| Sheetal Amit Kothekar | Director | 26 Nov 2012 | 13 Years 11 Months | Current |
Peer comparison
Forton Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Scynor Pharmaceuticals Private Limited | ₹32.2 Lakh (FY 2024) | 122.0% | Raisen, Madhya Pradesh, India | |||
| Forton Pharmaceuticals Private Limitedthis company | ₹32.12 Lakh (FY 2019) | ₹1.55 Lakh | 4.8% | 4.0% | Pune, Maharashtra, India | |
| Soleil Pharmaceuticals Private Limited | ₹32.1 Lakh (FY 2025) | -22.0% | Chennai, Tamil Nadu, India | |||
| Moonlight Pharmaceuticals Private Limited | ₹32.07 Lakh (FY 2017) | 16.0% | Sri Ganganagar, Rajasthan, India | |||
| Zonetics Pharmaceuticals Private Limited | ₹32.03 Lakh (FY 2025) | 31.0% | Gandhinagar, Gujarat, India |
To see the full peer comparison of Forton Pharmaceuticals Private Limited, buy the company report.
Auditor
Forton Pharmaceuticals Private Limited is audited by D GABSS ASSOCIATES CHARTERED ACCOUNTANTS for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D GABSS ASSOCIATES CHARTERED ACCOUNTANTS | FY 2017 | 122807W |
Shareholding
The shareholding of Forton Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Forton Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Forton Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Forton Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Forton Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Forton Pharmaceuticals Private Limited, buy the company report.
Recent activity
Forton Pharmaceuticals Private Limited has 3 board changes on record since 2012: 3 appointments. The latest: Sheetal Amit Kothekar was appointed as Director on 26 Nov 2012.
Frequently asked questions
Forton Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 26 November 2012 (14+ years old) and is registered under CIN U93000PN2012PTC145510.
Forton Pharmaceuticals has 3 current directors:
- Vinod Jijeba Gote - Director
- Shital Lalitkumar Kabra - Director
- Sheetal Amit Kothekar - Director
The latest financial statements of Forton Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Forton Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Forton Pharmaceuticals is U93000PN2012PTC145510. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Forton Pharmaceuticals was incorporated on 26 November 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Forton Pharmaceuticals by revenue are Scynor Pharmaceuticals Private Limited, Soleil Pharmaceuticals Private Limited, Moonlight Pharmaceuticals Private Limited, Zonetics Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sheetal Amit Kothekar was appointed as Director on 26 Nov 2012. Shital Lalitkumar Kabra was appointed as Director on 26 Nov 2012. Vinod Jijeba Gote was appointed as Director on 26 Nov 2012.
The registered office of Forton Pharmaceuticals is at Flat No. 4 Amey Co – Operative Housing Society V – 10 Indira Shankar Nagri Paud Road K, Othrud, Pune, Maharashtra, India – 411038.
Forton Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Forton Pharmaceuticals is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
